CORE in the News
Since arriving at Yale School of Medicine in 2019 as an internal medicine resident, Evangelos Oikonomou, MD, DPhil—now an assistant professor of medicine (cardiovascular medicine)—has focused his research on developing artificial intelligence (AI) applications that can interpret traditional, routine cardiac tests to better assist providers in diagnosing cardiovascular diseases. In a new paper published in NEJM AI, Oikonomou, together with Rohan Khera, MD, MS and their colleagues from the Yale Cardiovascular Data Science (CarDS) Lab, shared a new AI-enabled clinical decision support tool, TARGET-AI, designed to help clinicians and their larger health systems use AI more effectively.
- December 15, 2025
Congratulations to the following Yale Department of Internal Medicine faculty members, who were recently promoted, appointed, or reappointed.
- November 20, 2025Source: Yale Medicine
Stress can cause inflammation and damage the heart. Yale experts recommend ways to manage that stress and keep your heart healthy.
- November 18, 2025
Yale faculty, trainees, and staff will share some of the latest updates on cardiovascular care at the upcoming Masters of Medicine Conference in Kingston, Jamaica, from January 16-18, 2026. The annual conference, hosted by the Heart Institute of the Caribbean (HIC) and the HIC Foundation (HICF), aims to accelerate the development of evidence-based cardiovascular care in Jamaica and throughout the Caribbean.
- November 17, 2025
A new study led by Yale’s Jennifer Miller, PhD, found that medicines are not physically accessible in many of the countries where they are tested for FDA approval.
- October 14, 2025
The Yale Department of Internal Medicine congratulates some of the new professors in the department, including Marjorie Golden, MD; Ladan Golestaneh, MD, MS; William Oh, MD; and Christine Won, MD, MSc.
- September 18, 2025Source: U.S. News & World Report
Nearly 4 out of 5 American neurologists prescribing multiple sclerosis (MS) drugs have received at least one payment from the pharmaceutical industry, a new study reports.
- September 16, 2025
Meet clinical fellow, Joshua Skydel, MD, who aims to develop methods for using real-world data to evaluate the safety and effectiveness of disease-modifying antirheumatic drugs
- September 09, 2025Source: Financial Times
“Hypertension is the leading preventable cause of heart attack and stroke, yet millions remain undiagnosed. Making accurate detection easy and part of daily life can help people get care earlier and prevent avoidable harm,” explained Yale School of Medicine cardiologist Harlan Krumholz.
- September 02, 2025Source: Healthcare Dive
Public companies, which accounted for about half of AI-enabled devices on the market, had a higher rate of recalls and a lower rate of clinical evidence, according to a JAMA study, co-authored by Yale's Dr. Joseph Ross.